Rights and permissions
About this article
Cite this article
Peginterferon-α + ribavirin in hep C nonresponders can be worth it. Pharmacoecon. Outcomes News 480, 8 (2005). https://doi.org/10.2165/00151234-200504800-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504800-00023